WELCOME TO The chemical REPORT
Newsletter | Member Login | Signup
Home > Companies > Genesis Biotechnology Group
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Conference
Ohio Environmental Protection Agency | June 23, 2020
A Thailand-based petrochemical company has received an extension from the Ohio Environmental Protection Agency for for its air permit for a proposed ethane-ethylene cracker plant along the Ohio River in Belmont County. The extension exempts the company from having to do a new analysis to determine whether national air quality standards would be violated. An air quality permit for a proposed multibillion-dollar petrochemical plant in eastern Ohio was set to expire Monday. But in a ...
EPA | January 14, 2020
A Torrance, Calif.-based petroleum refinery has agreed to pay $125,000 after violating the Clean Air Act’s Chemical Accident Prevention Program. The U.S. Environmental Protection Agency settled with Torrance Refining Company LLC after discovering deficiencies in its chemical safety and risk management plan. “It is critical for the refinery to maintain an up-to-date and accurate Risk Management Plan,” said EPA Pacific Southwest Regional Administrator Mike Stoker in a statement.&...
Chemical Technology, Chemical Management
Talos Energy Inc. | February 15, 2023
Talos Energy Inc. announces that its previously disclosed acquisition of EnVen Energy Corporation has been finalized. The firm anticipates providing investors with 2023 financial and operational guidance for the merged company simultaneously with the full year 2022 results press release to be delivered on February 28, 2023. Upon completion of the transaction, Talos will now have about 126,370,000 shares of outstanding common stock and a market value of approximately $2.5 billion...
Chemical Management
NextDecade Corporation | September 16, 2022
NextDecade Corporation announced a private placement of common stock pursuant to which NextDecade will sell $85 million of common stock to 10 institutional investors. Shares of NextDecade’s common stock will be sold at $5.50 per share, and the private placement is expected to close on September 19, 2022, subject to the satisfaction of customary closing conditions. The Company intends to use the proceeds from the private placement to continue development activity in preparati...
Article
infographic
Chemical Technology, Science and Research
Video
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE